|
1
|
International Agency for Research on
Cancer, . World Health OrganizationLatest world cancer statistics.
IARC; Lyon: 2013
|
|
2
|
American Society of Clinical Oncology
(ASCO), . Cervical cancer: Statistics. http://www.cancer.net/cancer-types/cervical-cancer/statistics
|
|
3
|
Korean statistical information service, .
Statistics Korea. Statistics Korea, Daejeon. 2012, http://kosis.kr
|
|
4
|
Seol HJ, Ki KD and Lee JM: Epidemiologic
characteristics of cervical cancer in Korean women. J Gynecol
Oncol. 25:70–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kuo DY, Blank SV, Christos PJ, Kim M,
Caputo TA, Pothuri B, Hershman D, Goldman N, Ivy PS, Runowicz CD,
et al: Paclitaxel plus oxaliplatin for recurrent or metastatic
cervical cancer: A New York cancer consortium study. Gynecol Oncol.
116:442–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Wit R, van der Zee J, van der Burg ME,
Kruit WH, Logmans A, van Rhoon GC and Verweij J: A phase I/II study
of combined weekly systemic cisplatin and locoregional hyperthermia
in patients with previously irradiated recurrent carcinoma of the
uterine cervix. Br J Cancer. 80:1387–1391. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rietbroek RC, Schilthuis MS, Bakker PJ,
van Dijk JD, Postma AJ, González González D, Bakker AJ, van der
Velden J, Helmerhorst TJ and Veenhof CH: Phase II trial of weekly
locoregional hyperthermia and cisplatin in patients with a
previously irradiated recurrent carcinoma of the uterine cervix.
Cancer. 79:935–943. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones EL, Samulski TV, Dewhirst MW,
Alvarez-Secord A, Berchuck A, Clarke-Pearson D, Havrilesky LJ,
Soper J and Prosnitz LR: A pilot phase II trial of concurrent
radiotherapy, chemotherapy, and hyperthermia for locally advanced
cervical carcinoma. Cancer. 98:277–282. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsuda H, Tanaka M, Manabe T, Ikeda H,
Negoro S, Ishiko O and Yamamoto K: Phase I study of combined
radiation, hyperthermia and intra-arterial carboplatin for local
recurrence of cervical cancer. Ann Oncol. 14:298–303. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Westermann AM, Jones EL, Schem BC, van der
Steen-Banasik EM, Koper P, Mella O, Uitterhoeve AL, de Wit R, van
der Velden J, Burger C, et al: First results of triple-modality
treatment combining radiotherapy, chemotherapy, and hyperthermia
for the treatment of patients with stage IIB III, and IVA cervical
carcinoma. Cancer. 104:763–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Franckena M, de Wit R, Ansink AC,
Notenboom A, Canters RA, Fatehi D, Van Rhoon GC and Van Der Zee J:
Weekly systemic cisplatin plus locoregional hyperthermia: An
effective treatment for patients with recurrent cervical carcinoma
in a previously irradiated area. Int J Hyperthermia. 23:443–450.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dahl O: Interaction of heat and drugs in
vitro and in vivoThermoradiotherapy and Thermochemotherapy.
Seegenschmiedt MH, Fessenden P and Vernon CC: 1. Springer Verlag;
Berlin: pp. 103–121. 1995, View Article : Google Scholar
|
|
13
|
Hegyi G, Szigeti GP and Szász A:
Hyperthermia versus oncothermia: Cellular effects in complementary
cancer therapy. Evid Based Complement Alternat Med.
2013:6728732013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Andocs G, Okamoto Y, Kawamoto K, Osaki T,
Tsuka T, Imagawa T, Minami S, Balogh L, Meggyeshazi N and Szasz O:
Oncothermia basic research at in vivo level: The first results in
Japan. Conference Papers Med. 2013:pp. 1973282013;
|
|
15
|
Szasz A, Vincze G, Szasz O and Szasz N: An
energy analysis of extracellular hyperthermia. Electromagn Biol
Med. 22:103–115. 2003. View Article : Google Scholar
|
|
16
|
Meggyeshazi N, Andocs G, Balogh L, Balla
P, Kiszner G, Teleki I, Jeney A and Krenacs T: DNA fragmentation
and caspase-independent programmed cell death by modulated
electrohyperthermia. Strahlenther Onkol. 190:815–822. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Andocs G, Meggyeshazi N, Balogh L, Spisak
S, Maros ME, Balla P, Kiszner G, Teleki I, Kovago C and Krenacs T:
Upregulation of heat shock proteins and the promotion of damage
associated molecular pattern signals in a colorectal cancer model
by modulated electro-hyperthermia. Cell Stress Chaperones.
20:37–46. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Szasz A: Challenges and solutions in
oncological hyperthermia. Med. 29:1–23. 2013.
|
|
19
|
Fiorentini G, Giovanis P, Rossi S, Dentico
P, Paola R, Turrisi G and Bernardeschi P: A phase II clinical study
on relapsed malignant gliomas treated with electro-hyperthermia. In
Vivo. 20:721–724. 2006.PubMed/NCBI
|
|
20
|
Hager ED, Sahinbas H, Groenemeyer DH and
Migeod F: Prospective phase II trial for recurrent high-grade
malignant gliomas with capacitive coupled low radiofrequency (LRF)
deep hyperthermia. J Clin Oncol. 26:20472008. View Article : Google Scholar
|
|
21
|
Sahinbas H, Grönemeyer DH, Böcher E and
Szasz A: Retrospective clinical study of adjuvant
electro-hyperthermia treatment for advanced brain-gliomas. Dtsch Z
Onkol. 39:154–160. 2007. View Article : Google Scholar
|
|
22
|
Wismeth C, Dudel C, Pascher C, Ramm P,
Pietsch T, Hirschmann B, Reinert C, Proescholdt M, Rümmele P,
Schuierer G, et al: Transcranial electro-hyperthermia combined with
alkylating chemotherapy in patients with relapsed high-grade
gliomas: Phase I clinical results. J Neurooncol. 98:395–405. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Andocs G, Szasz O and Szasz A: Oncothermia
treatment of cancer: From the laboratory to clinic. Electromagn
Biol Med. 28:148–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szasz A: Current status of oncothermia
therapy for Lung cancer. Korean J Thorac Cardiovasc Surg. 47:77–93.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeung TS, Ma SY, Yu J and Lim S: Cases
that respond to Oncothermia Monotherapy. Conference Papers Med.
2013:pp. 3924802013;
|
|
26
|
Szasz A, Iluri N and Szasz O: Local
hyperthermia in oncology-to choose or not to choose?Hyperthermia.
Huilgol N: InTech; Croatia: pp. 1–82. 2013
|
|
27
|
Gonzalez-Gonzalez D: Thermo-radiotherapy
for tumors of the lower gastro-instenstinal tractThermoradiotherapy
and thermochemiotherapy: Biology, physiology, physics.
Seegenschmiedt MH, Fessenden P and Vernon CC: Springer Verlag;
Berlin: pp. 105–109. 1996, View Article : Google Scholar
|
|
28
|
Brader KR, Morris M, Levenback C, Levy L,
Lucas KR and Gershenson DM: Chemotherapy for cervical carcinoma:
Factors determining response and implications for clinical trial
design. J Clin Oncol. 16:1879–1884. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Potter ME, Hatch KD, Potter MY, Shingleton
HM and Baker VV: Factors affecting the response of recurrent
squamous cell carcinoma of the cervix to cisplatin. Cancer.
63:1283–1286. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Green DM, Burton GV, Cox EB, Hanson D,
Moore J and Oleson JR: A phase I/II study of combined cisplatin and
hyperthermia treatment for refractory malignancy. Int J
Hyperthermia. 5:13–21. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Song CW: Effect of local hyperthermia on
blood flow and microenvironment: A review. Cancer Res. 44 10
Suppl:4721s–4730s. 1984.PubMed/NCBI
|
|
32
|
Hegyi G, Vincze G and Szasz A: On the
dynamic equilibrium in homeostasis. Open J Biophys. 2:64–71. 2012.
View Article : Google Scholar
|
|
33
|
Urano M, Kuroda M and Nishimura Y: For the
clinical application of thermochemotherapy given at mild
temperatures. Int J Hyperthermia. 15:79–107. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Urano M, Wong KH, Reynolds R and Begley J:
The advantageous use of hypoxic tumour cells in cancer therapy:
Identical chemosensitization by metronidazole and misonidazole at
moderately elevated temperatures. Int J Hyperthermia. 11:379–388.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Heijkoop ST, van Doorn HC, Stalpers LJ,
Boere IA, van der Velden J, Franckena M and Westermann AM: Results
of concurrent chemotherapy and hyperthermia in patients with
recurrent cervical cancer after previous chemoradiation. Int J
Hyperthermia. 30:6–10. 2014. View Article : Google Scholar : PubMed/NCBI
|
